Rheumatology clinical trials recruiting in New York

13 recruiting rheumatology trials match in New York. Showing 13.

• Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)Recruiting

  Phase 2 · Autolus Limited · New York, New York

• A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132Recruiting

  Phase 4 · Bristol-Myers Squibb · New York, New York

• Guselkumab vs Golimumab in PsA TNF Inadequate Responder PatientsRecruiting

  Phase 3 · University of Pennsylvania · New York, New York

• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric ParticipantsRecruiting

  Phase 2 · Hoffmann-La Roche · Queens, New York

• Effects of Stopping Hydroxychloroquine in Elderly Lupus DiseaseRecruiting

  Phase 3 · NYU Langone Health · New York, New York

• Observational Study of Pediatric Rheumatic Diseases: The CARRA RegistryRecruiting

  N/A · Duke University · Albany, New York

• Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and OsteoarthritisRecruiting

  Phase 3 · Medipost, Inc. · Flushing, New York

• A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's DiseaseRecruiting

  Phase 1 · Cullinan Therapeutics Inc. · Brooklyn, New York

• RA-PRO PRAGMATIC TRIALRecruiting

  Phase 3 · University of Alabama at Birmingham · New York, New York

• VIBRANT: VIB4920 for Active Lupus NephritisRecruiting

  Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID) · Manhasset, New York

• A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the KneeRecruiting

  Phase 2 · Pacira Pharmaceuticals, Inc · Huntington Beach, California

• A Multi-Center Study Assessing the Safety and Efficacy of the LEGION Medial Stabilized (MS) Insert in Patients Undergoing a Total Knee Arthroplasty (TKA)Recruiting

  N/A · Smith & Nephew, Inc. · New York, New York

• Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).Recruiting

  Phase 1 · Novartis Pharmaceuticals · New York, New York

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.